PBYI
PUMA BIOTECHNOLOGY INC
stockNASDAQ
At CloseOct 2, 2026 3:59:56 PM EDT
9.51USD-3.354%(-0.33)454,882
Pre-marketOct 2, 2026 8:45:30 AM EDT
9.84USD0.000%(0.00)
After-hoursOct 2, 2026 4:54:30 PM EDT
9.45USD-0.631%(-0.06)
Loading…
Loading…
490.39M
Healthcare
Biotechnology
HQ
Los Angeles, CA, USA
318
Previous Close
$9.84
Beta
0.52
52-Week High
$10.10 2026-09-30
52-Week Low
$4.58 2025-11-11
SMA 50
$9.03
SMA 200
$7.47
Avg. Vol 10D
362,263
Avg. Vol 30D
315,601
Avg. Vol 90D
318,209
Relative Vol
1.44
51.62M
38.90M
75.37%
4,319,663
11.10%
13.80
59%/41%
71.04%
56.77%
0.4100%
1,600,000
692
692
Nov 5, 2026 (31d)
Sep 17, 2026
Puma Biotechnology initiates phase II lung cancer trial · 
Investing.com
Sep 16, 2026
Puma biotechnology director Cesano sells shares worth $566,994 · Investing.com
Puma Biotechnology director Troy Wilson sells $45,500 in stock · Investing.com
Sep 9, 2026
Axsome (AXSM) Down 3.7% Since Last Earnings Report: Can It Rebound? · 
Zacks Investment Research
PBYI Profile
we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
PBYI Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 9.82 | 2026-09-28 | -3.26% | -4.218 |
| 1M | 9.55 | 2026-09-04 | -0.52% | 0.156 |
| 3M | 8.22 | 2026-07-06 | +15.57% | 0.241 |
| 6M | 6.89 | 2026-04-06 | +37.88% | 0.415 |
| 1Y | 5.13 | 2025-10-03 | +85.19% | 0.521 |
| 2Y | 2.65 | 2024-10-04 | +258.49% | — |
| 5Y | 6.27 | 2021-10-04 | +51.52% | 0.956 |
PBYI Stock Summary
PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) stock price today is $9.50, and today's volume is 454,882. PBYI is down 3.455% today. The 30 day average volume is 315,601. PBYI market cap is $490.39M with 51.62M shares outstanding.